The current stock price of THRN is 10.19 USD. In the past year, price increased by 121.52%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 63.86 | 38.66B | ||
| KVUE | KENVUE INC | 16.19 | 33.18B | ||
| ELF | ELF BEAUTY INC | 25.44 | 4.67B | ||
| BRBR | BELLRING BRANDS INC | 15.35 | 3.99B | ||
| COTY | COTY INC-CL A | 17.74 | 2.95B | ||
| IPAR | INTERPARFUMS INC | 15.81 | 2.66B | ||
| OLPX | OLAPLEX HOLDINGS INC | 17 | 907.81M | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.82 | 805.15M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.5 | 504.56M | ||
| NATR | NATURES SUNSHINE PRODS INC | 23.23 | 382.20M | ||
| USNA | USANA HEALTH SCIENCES INC | 10.65 | 381.50M | ||
| HNST | HONEST CO INC/THE | 48.17 | 323.07M |
Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. The company is headquartered in Summerville, South Carolina and currently employs 544 full-time employees. The company went IPO on 2021-09-23. The Company’s vertically integrated brands, Thorne and Onegevity, provide actionable insights and personalized data, products and services that individuals to take a proactive approach to improve and maintain their health over their lifetime. By combining its multi-omics database, artificial intelligence (AI) and digital health content with its science-backed nutritional supplements, it delivers a total system for wellness. Thorne provides health tests, education, and products that support the optimization of health. Onegevity provides a comprehensive molecular portrait and personalized recommendations for an individual’s health, based on integrated analysis of longitudinal blood, genetics and gut microbiome profiles. The company offers health tests to generate comprehensive, personalized molecular portraits for its customers.
THORNE HEALTHTECH INC
620 Omni Industrial Blvd.
Summerville SOUTH CAROLINA US
CEO: Paul F. Jacobson
Employees: 544
Phone: 18435010286.0
Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. The company is headquartered in Summerville, South Carolina and currently employs 544 full-time employees. The company went IPO on 2021-09-23. The Company’s vertically integrated brands, Thorne and Onegevity, provide actionable insights and personalized data, products and services that individuals to take a proactive approach to improve and maintain their health over their lifetime. By combining its multi-omics database, artificial intelligence (AI) and digital health content with its science-backed nutritional supplements, it delivers a total system for wellness. Thorne provides health tests, education, and products that support the optimization of health. Onegevity provides a comprehensive molecular portrait and personalized recommendations for an individual’s health, based on integrated analysis of longitudinal blood, genetics and gut microbiome profiles. The company offers health tests to generate comprehensive, personalized molecular portraits for its customers.
The current stock price of THRN is 10.19 USD. The price decreased by -0.1% in the last trading session.
THRN does not pay a dividend.
THRN has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
THORNE HEALTHTECH INC (THRN) has a market capitalization of 550.67M USD. This makes THRN a Small Cap stock.
THORNE HEALTHTECH INC (THRN) will report earnings on 2023-11-09, after the market close.
ChartMill assigns a technical rating of 8 / 10 to THRN. When comparing the yearly performance of all stocks, THRN is one of the better performing stocks in the market, outperforming 99.36% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to THRN. Both the profitability and the financial health of THRN get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months THRN reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS increased by 660% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.94% | ||
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| Debt/Equity | 0.17 |
10 analysts have analysed THRN and the average price target is 8.61 USD. This implies a price decrease of -15.52% is expected in the next year compared to the current price of 10.19.
For the next year, analysts expect an EPS growth of 14.31% and a revenue growth 23.62% for THRN